Navigation Links
USP publishes Spanish edition of United States Pharmacopeia and National Formulary
Date:2/4/2008

Rockville, Md., February 4, 2008 The U.S. Pharmacopeia (USP) is pleased to announce that the third annual Spanish edition of its core compendia, the United States Pharmacopeia and National Formulary (USPNF), is now available for purchase. The official edition for 2008, USP 31NF 26, provides specifications needed to produce more than 4,000 quality pharmaceuticals, excipients, dietary supplements, biologics and other therapeutics.

USPNF, recognized by U.S. federal law as the official compendia for drug standards, offers access to monographs defining the required standards for the identity, quality, purity, strength, labeling and packaging for prescription and over-the-counter medications, dietary supplements and other health care products. These standards are enforceable by the U.S. Food and Drug Administration for drugs marketed in or exported to the United States, and are also recognized by governments and regulatory agencies throughout the world.

USP is proud to offer a Spanish edition of the USPNF for the third year in a row, said Darrell Abernethy, M.D., Ph.D., chief science officer of USP. By translating the compendia, we hope to better meet the needs of our Spanish-speaking partners as we work together to advance USPs mission of providing good pharmaceutical care for all people, all over the world.

The Spanish edition, Farmacopea de los Estados Unidos de Amrica-Formulario National, is an official, expert translation of the USPNF in English. Written in a universal, neutral Spanish, the translation process is supervised by USPs Spanish Advisory Panela dedicated body of leading scientific experts from Spanish-speaking countries. USP offers expert scientific and technical support in Spanish during business hours that are convenient for Spanish-speaking customers.

USPNF is used by quality assurance and quality control scientists, pharmaceutical manufacturers, regulatory professionals, compounding professionals, lawyers, and pharmacy and medical schools all over the world. In addition to monograph standards, USP 31NF 26 provides more than 200 general chapters covering general tests and assays, and information on emerging areas of science and medicine.


'/>"/>

Contact: Sandra Kim
sek@usp.org
301-816-8241
US Pharmacopeia
Source:Eurekalert

Related medicine news :

1. The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
2. American College of Physicians publishes The Fenway Guide to LGBT Health
3. In Honor of Hispanic Heritage Month and Spanish Speakers Worldwide International Hyperhidrosis Society Publishes Important New Patient Booklet in Spanish
4. Multiple Sclerosis Association of America Publishes Booklet about Depression in Multiple Sclerosis
5. American College of Physicians publishes "Peripheral Arterial Disease"
6. Thomson Scientific Publishes Who Is Making The Biggest Splash? - a Quarterly Review of Scientific Literature on Drugs and Therapies From July - September 2007
7. Thomson Scientific Publishes its Third Quarter Issue of the Ones to Watch Reviewing the Most Promising Drugs in the Pharmaceutical Pipeline
8. The Endocrine Society Publishes White Paper Calling for Greater Minority Participation in Clinical Research
9. Springer publishes La Chirurgia degli Organi de Movimento
10. The Diabetes Educator publishes systematic reviews for diabetes management
11. USP Publishes Spanish Edition of United States Pharmacopeia and National Formulary
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... Usually, the impending arrival ... wardrobe. However, for those self-conscious about a double chin, this means more anxiety than ... solution. , “For most people, a double chin is undesirable,” Dr. Goldman said, ...
(Date:3/28/2017)... , ... March 28, 2017 , ... ... Wethersfield, Conn., has relocated its corporate headquarters to a new, more expansive office ... , In October 2016, Qualidigm purchased a distressed office building in Wethersfield, Conn. ...
(Date:3/28/2017)... ... 28, 2017 , ... In its ongoing effort to educate ... developed and published an informational resource that addresses frequently asked questions. , ... the site’s team of third party administrator (TPA) contributors regularly receives as employers, ...
(Date:3/28/2017)... Angeles, CA (PRWEB) , ... March 28, 2017 ... ... credential, which will be offered by the American Association of Integrative Medicine and ... presentations for healthcare providers at the AutismOne 2017 Conference in Colorado Springs. , ...
(Date:3/28/2017)... ... March 28, 2017 , ... With expansion and efficiency in mind, ... March. , The seed processing plant opened in Marshallville in 2006, and a bagging ... office allows opportunity for transition of Patten Seed operations to the Middle Georgia location ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... , March 27, 2017  Sanderling Ventures, portfolio ... Ethicon, a division of Johnson & Johnson. Torax manufactures ... the treatment of gastro-esophageal reflux disease (GERD). The ... (MSA) technology and the procedure is currently available ... Torax Medical was founded by Sanderling Ventures, ...
(Date:3/27/2017)... FinancialBuzz.com News Commentary  ... According to a new report by Arcview Market Research, the ... 34 percent to $6.7 billion and can be expected to grow at ... five years, from $6.7 billion in 2016, to $22.6 billion in 2021. ... to purchase cannabis without a doctor,s recommendation. Voters in California ...
(Date:3/27/2017)... 2017 The staggering cost of cancer treatment ... access to the latest treatment options against cancer. Even ... patients have inadequate or no health insurance and are ... Access to modern cancer treatment is almost non-existent for ... The mission statements of pharmaceutical and biotech companies ...
Breaking Medicine Technology: